Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controlsM Deuschle, U Schweiger, B Weber, et al.Journal of Clinical Pharmacology|March 1, 1997
Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P-450 2C9 and metabolic inhibitorsJ Schmider, D J Greenblatt, L L von Moltke, et al.Journal of Clinical Psychopharmacology|June 1, 1997
Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) systemM Deuschle, J Schmider, B Weber, et al.Depression and Anxiety|October 24, 1998
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatmentI Heuser, G Bissette, M Dettling, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 1999
O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressantsS M Fogelman, J Schmider, K Venkatakrishnan, et al.Pharmacology|February 1, 1996
Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodiesJ Schmider, D J Greenblatt, L L von Moltke, et al.Molecular Psychiatry|April 24, 2001
Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophreniaR Kaiser, P B Tremblay, J Schmider, et al.Psychopharmacology|October 21, 2000
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatientsM Dettling, C Sachse, J Brockmöller, et al.Journal of Clinical Pharmacology|September 1, 1996
Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agentsL L von Moltke, D J Greenblatt, J Schmider, et al.Biological Psychiatry|June 2, 1998
The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression testM Deuschle, U Schweiger, U Gotthardt, et al.Pageof 4